|
Program |
Date |
Abstract | Notes | Applied Pharmaceutical Software 2008 | July 30, 2008 | YES | NO | 2008 Rozman Memorial Symposium | June 12, 2008 | YES | NO | Cellular Membrane Affinity Chromatography (CMAC): Working at the intersection of Chromatographic and Biological Sciences | April 23, 2008 | YES | NO |
Workshop on Current Topics in GLP Bioanalysis Assay.
Reproducibility for Incurred Samples - Implications of Crystal City Recommendations | March 19, 2008 | YES | NO | Characterization of Drug Transporters Expression in Liver Following Toxic Acetaminophen Exposure. | December 5, 2007 | YES | NO | 2007 Robert S. Rozman Memorial Symposium | May 24, 2007 | YES | NO | Crystal City III White Paper "Quantitative Bioanalytical Methods Validation and Implementation:Best Practices for Chromatographic and Ligand Binding Assays | April 17, 2007 | Yes | NO |
| Two Speakers on e-INDS | October 17, 2006 | No |
|
| Rozman Symposium: Topics TBD | May 24, 2006 | No |
|
| The Bioanalytical Validation Guidance: Past, Present and Future |
February 22, 2006 | No |
|
| ADME Outsouring: Scientific and Operations Issues |
December 8, 2005 | No |
|
| IS DRUG HUNTING DEAD? | November 3,2005 | No |
|
| Pharmaceutical Development - Introduction to Immunoassays and Their Application to PK | September 28, 2005 | No |
|
| 2005 Robert S. Rozman Memorial Symposium | June 8, 2005 | No |
|
| Challenges and Opportunities in the Development of Therapeutic Proteins | April 21, 2005 | No |
|
| Predictive Drug Metabolism, Induction and Interaction | December 8, 2004 | No |
|
| ADME and Toxicology in Drug Discovery Symposium | December 11, 2002 | No |
No |
F. Peter Guengerich
| November 7, 2002 | Yes | No |
| Dr. Michie I. Hunt on "Recent Trends in Pharmaceutical Innovation
| October 15, 2002 | Yes | No |
| The 2002 Rozman Symposium
| May 14th, 2002 | Yes | No |
| Dr. Leslie M. Shaw Professor of Pathology and Laboratory Medicine University of Pennsylvania Health System (UPHS) Implications for the Transplant Patient | March 14, 2002 | Yes | No |
| Lewis Klunk, Ph.D. Executive Director, Biotransformation, Bristol-Myers Squibb Metabolites in Safety Testing (MIST). | January 30, 2002 | Yes | No |
| Thomas A. Baillie Department of Drug Metabolism Merck Research Laboratories COVALENT BINDING IN DRUG DISCOVERY AND DEVELOPMENT. A PRAGMATIC VIEW OF THE ISSUE OF REACTIVE INTERMEDIATES. | November 8, 2001 | Yes | No |
| Industry and Regulatory Authorities "Plasma Protein Binding: Pharmacokinetic, Regulatory and Analytical Issues" | November 28, 2001 | Yes | No |
| Patrick Loll Assistant Professor of Pharmacology University of Pennsylvania, School of Medicine | September 20, 2001 | Yes | No |
| John Shockcor, Ph.D Principle Research Scientist, DuPont Pharmaceutical Company |
December 9, 1998 | Yes | Yes |
| Anthony Y. H. Lu, Ph.D Adjunct Professor, School of Pharmacy Rutgers, The State University of New Jersey |
January 28, 1999 | Yes | No |
| Luana Pesco-Koplowitz, M.D., Ph.D (Group Director Janssen Research Foundation) | March 9, 1999 | ||
|
Reducing Impact of Animal Stress on Pharmacokinetics... |
March 26, 2003 | No | Yes |